Novel cardiovascular protective effects of RhoA signaling and its therapeutic implications

Joanne Ern Chi Soh1, Akio Shimizu1, Akira Sato1

  • 1Division of Molecular Medical Biochemistry, Department of Biochemistry and Molecular Biology, Shiga University of Medical Science, Otsu, Japan.

Biochemical Pharmacology
|October 31, 2023
PubMed

Insights

Ras homolog gene family member A (RhoA) is vital in cardiovascular health, regulating cardiac remodeling. Further research into RhoA signaling could reveal new therapeutic targets for cardiovascular diseases.

Area of Science:

  • Cardiovascular Biology
  • Molecular Cell Biology
  • Biochemistry

Background:

  • Ras homolog gene family member A (RhoA) is a key regulator of cellular function within the Rho GTPase superfamily.
  • RhoA influences cell signaling, gene transcription, and cytoskeleton dynamics, impacting cellular processes.
  • Its role in cardiovascular diseases, particularly cardiac remodeling, is recognized but not fully understood.

Purpose of the Study:

  • To review the characteristics of RhoA and its associated signaling molecules.
  • To provide an overview of RhoA's functions in physiological and pathological cardiovascular conditions.
  • To update knowledge on novel RhoA signaling pathways in the cardiovascular system and potential therapeutic targets.

Main Methods:

  • Literature review of studies on RhoA in cardiovascular physiology and pathology.
  • Analysis of RhoA's role in actin stress fiber dynamics and cytoskeleton formation.
  • Synthesis of current understanding of RhoA signaling pathways and cellular responses.

Main Results:

  • RhoA is a critical regulator of cardiac remodeling through cytoskeleton modulation.
  • RhoA signaling pathways are implicated in both normal cardiovascular function and disease states.
  • Understanding RhoA's mechanisms is essential for clarifying its protective role in the cardiovascular system.

Conclusions:

  • RhoA plays a significant role in cardiovascular diseases, particularly in cardiac remodeling.
  • Further elucidation of RhoA's novel signaling mechanisms is needed.
  • RhoA represents a potential target for future cardiovascular therapies.

Related Concept Videos

Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
4.0K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
438
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.2K
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
12
Cell Polarization by Rho Proteins01:21

Cell Polarization by Rho Proteins

Cell polarity is the asymmetric distribution of cellular and membrane components, making one side of the cell different from the other. This polarity is essential to many processes such as embryogenesis, axon migration, glucose transport across epithelial cells, and directional cell migration. A migrating cell responds to intracellular or extracellular signals via molecular cascades that reorganize the actin cytoskeleton to establish this polarity. In these cells, the Rho family proteins Cdc42,...
2.7K